Middle East & Africa Custom Antibody Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The custom antibody services market in the Middle East and Africa is projected to grow from approximately US$ 16.65 million in 2023 to US$ 25.54 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.5% during this period.

Executive Summary and Market Analysis

The market is divided into key regions including the UAE, Saudi Arabia, South Africa, and the broader Middle East and Africa. Several factors are driving growth in this sector, such as advancements in healthcare infrastructure, increased research and development activities, and a rise in the number of companies entering the market. The region is witnessing various research initiatives, enhanced access to high-tech research facilities (notably in the UAE and Saudi Arabia), and a growing prevalence of chronic and infectious diseases, alongside an aging population, all contributing to market expansion.

Market Segmentation

The Middle East and Africa custom antibody services market can be analyzed through several segments:

1. Product Type: The market is categorized into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.

2. Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading the market in 2023.

3. Application: The applications of custom antibodies include immunohistochemistry, western blotting, ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the most significant application in 2023.

4. Disease Indication: The market is segmented by disease indication into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.

5. Source: This includes sources such as chicken, rabbits, rats, guinea pigs, and mouse or humanized mice, with the latter holding the largest share in 2023. This segment further includes various platforms for monoclonal antibodies and other technologies.

6. End User: The end users are categorized into the life sciences industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life sciences industry dominating the market in 2023.

Market Outlook

The increasing elderly population, shifts in social behavior, and a rise in sedentary lifestyles are contributing to the prevalence of obesity and chronic diseases. Chronic diseases accounted for 74% of global deaths in 2019, with cardiovascular diseases (CVDs) being the leading cause of mortality, resulting in approximately 17.9 million deaths annually. The World Health Organization (WHO) reports that diabetes, affecting 425 million people in 2017, is expected to rise to 629 million by 2045, further driving the demand for custom antibodies.

The recognition of biosimilars and monoclonal antibodies as effective treatments is increasing their demand, as they provide cost-effective solutions for various chronic conditions, including cancer and autoimmune diseases. The rising prevalence of chronic diseases is significantly boosting the custom antibody services market.

Country Insights

The market includes key countries such as Saudi Arabia, South Africa, the UAE, and the rest of the Middle East and Africa, with Saudi Arabia holding the largest market share in 2023. The country is experiencing rapid healthcare development, with substantial investments in healthcare infrastructure, which supports the growth of custom antibody services. In 2021, Saudi Arabia allocated about 16% of its annual budget to healthcare, reflecting its commitment to enhancing healthcare services.

The incidence of cancer in Saudi Arabia is on the rise, with projections indicating an increase in new cases from 27,885 in 2020 to 60,429 by 2040. This surge in chronic diseases necessitates precise diagnostics and therapeutics, where custom antibodies play a crucial role in targeting specific biomarkers.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., Kaneka Eurogentec S.A., Fortis Life Sciences, Precision Antibody, Biocytogen Pharmaceuticals, Abgenex, Creative Biolabs Inc., Agilent Technologies Inc., Bioklone, and Scantibodies Laboratory, Inc. These companies are focusing on strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions.

Product Code: BMIRE00032164

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Middle East & Africa Custom Antibody Services Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Middle East & Africa Custom Antibody Services Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Rising Approvals of Biosimilars
5.2 Market Restraints
- 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
5.3 Market Opportunities
- 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
5.4 Future Trends
- 5.4.1 Technological Advancements Using Recombinant Antibodies
5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - Middle East & Africa Analysis

6.1 Middle East & Africa Custom Antibody Services Market Revenue (US$ Million), 2021-2031
6.2 Middle East & Africa Custom Antibody Services Market Forecast Analysis

7. Middle East & Africa Custom Antibody Services Market Analysis - by End User

7.1 Life Science Industry
- 7.1.1 Overview
- 7.1.2 Life Science Industry: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Pharmaceutical and Biotech Companies
- 7.2.1 Overview
- 7.2.2 Pharmaceutical and Biotech Companies: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Academic and Research Institutes
- 7.3.1 Overview
- 7.3.2 Academic and Research Institutes: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Contract Research Organizations
- 7.4.1 Overview
- 7.4.2 Contract Research Organizations: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Custom Antibody Services Market Analysis - by Disease Indication

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Infectious Diseases
- 8.2.1 Overview
- 8.2.2 Infectious Diseases: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Immunology: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cardiovascular Diseases
- 8.4.1 Overview
- 8.4.2 Cardiovascular Diseases: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Custom Antibody Services Market Analysis - by Source

9.1 Chicken
- 9.1.1 Overview
- 9.1.2 Chicken: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Rabbits
- 9.2.1 Overview
- 9.2.2 Rabbits: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Rats
- 9.3.1 Overview
- 9.3.2 Rats: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Guinea Pigs
- 9.4.1 Overview
- 9.4.2 Guinea Pigs: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Mouse or Humanized Mice
- 9.5.1 Overview
- 9.5.2 Mouse or Humanized Mice: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

10.1 Monoclonal Antibody Platform
- 10.1.1 Monoclonal Antibody Platform: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2 BsAb Discovery Platform
- 10.2.1 BsAb Discovery Platform: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Bispecific ADC Platform
- 10.3.1 Bispecific ADC Platform: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4 TCR-Mimic Antibody Platform
- 10.4.1 TCR-Mimic Antibody Platform: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Anti-GPCR Antibody Technology Platform
- 10.5.1 Anti-GPCR Antibody Technology Platform: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6 Others
- 10.6.1 Others: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Middle East & Africa Custom Antibody Services Market Analysis - by Application

11.1 Immunohistochemistry (IHC)
- 11.1.1 Overview
- 11.1.2 Immunohistochemistry (IHC): Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2 Western Blot and IP
- 11.2.1 Overview
- 11.2.2 Western Blot and IP: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3 ELISA
- 11.3.1 Overview
- 11.3.2 ELISA: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4 Fluorescence-activated cell sorting (FACS)
- 11.4.1 Overview
- 11.4.2 Fluorescence-activated cell sorting (FACS): Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5 Mass Spectrometry
- 11.5.1 Overview
- 11.5.2 Mass Spectrometry: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. Middle East & Africa Custom Antibody Services Market Analysis - by Service Type

12.1 Antibody Discovery and Development
- 12.1.1 Overview
- 12.1.2 Antibody Discovery and Development: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2 Antibody Production Services
- 12.2.1 Overview
- 12.2.2 Antibody Production Services: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3 Others
- 12.3.1 Overview
- 12.3.2 Others: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. Middle East & Africa Custom Antibody Services Market Analysis - by Product Type

13.1 Monoclonal
- 13.1.1 Overview
- 13.1.2 Monoclonal: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.2 Polyclonal hybridoma
- 13.2.1 Overview
- 13.2.2 Polyclonal hybridoma: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.3 Recombinant antibody
- 13.3.1 Overview
- 13.3.2 Recombinant antibody: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.4 Others
- 13.4.1 Overview
- 13.4.2 Others: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. Middle East & Africa Custom Antibody Services Market - Country Analysis

14.1 Middle East & Africa
- 14.1.1 Middle East & Africa Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.1 Middle East & Africa Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.2 Saudi Arabia: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.2.1 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by End User
    - 14.1.1.2.2 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.2.3 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by Source
    - 14.1.1.2.4 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.2.5 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by Application
    - 14.1.1.2.6 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by Service Type
    - 14.1.1.2.7 Saudi Arabia: Middle East & Africa Custom Antibody Services Market Share - by Product Type
  - 14.1.1.3 South Africa: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.3.1 South Africa: Middle East & Africa Custom Antibody Services Market Share - by End User
    - 14.1.1.3.2 South Africa: Middle East & Africa Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.3.3 South Africa: Middle East & Africa Custom Antibody Services Market Share - by Source
    - 14.1.1.3.4 South Africa: Middle East & Africa Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.3.5 South Africa: Middle East & Africa Custom Antibody Services Market Share - by Application
    - 14.1.1.3.6 South Africa: Middle East & Africa Custom Antibody Services Market Share - by Service Type
    - 14.1.1.3.7 South Africa: Middle East & Africa Custom Antibody Services Market Share - by Product Type
  - 14.1.1.4 United Arab Emirates: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.4.1 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by End User
    - 14.1.1.4.2 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.4.3 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by Source
    - 14.1.1.4.4 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.4.5 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by Application
    - 14.1.1.4.6 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by Service Type
    - 14.1.1.4.7 United Arab Emirates: Middle East & Africa Custom Antibody Services Market Share - by Product Type
  - 14.1.1.5 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by End User
    - 14.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by Source
    - 14.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by Application
    - 14.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by Service Type
    - 14.1.1.5.7 Rest of Middle East & Africa: Middle East & Africa Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

15.1 Overview
15.2 Growth Strategies in Custom Antibody Services Market
15.3 Organic Growth Strategies
- 15.3.1 Overview
15.4 Inorganic Growth Strategies
- 15.4.1 Overview

16. Company Profiles

16.1 Thermo Fisher Scientific Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Sino Biological Inc.
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 GenScript Biotech Corporation
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Biochain Incorporated
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 R&D Systems, Inc
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Kaneka Eurogentec S.A.
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Fortis Life Sciences
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Abgenex
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Creative Biolabs Inc
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Agilent Technologies Inc
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments
16.13 Bioklone
- 16.13.1 Key Facts
- 16.13.2 Business Description
- 16.13.3 Products and Services
- 16.13.4 Financial Overview
- 16.13.5 SWOT Analysis
- 16.13.6 Key Developments
16.14 Scantibodies Laboratory, Inc.
- 16.14.1 Key Facts
- 16.14.2 Business Description
- 16.14.3 Products and Services
- 16.14.4 Financial Overview
- 16.14.5 SWOT Analysis
- 16.14.6 Key Developments

17. Appendix

17.1 About The Insight Partners
17.2 Glossary of Terms